Medicare Enrolled
Dr. Melissa Krueger, APN
Registered Nurse · Hinsdale, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Krueger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krueger?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Krueger
Dr. Melissa Krueger is a registered nurse in Hinsdale, IL, with 4 years of NPI registration. Based on federal Medicare data, Dr. Krueger performed 37,852 Medicare services across 1,160 unique beneficiaries.
Between the years covered by Open Payments, Dr. Krueger received a total of $4,056 from 43 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krueger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 4 years in practice
▲ Top 0% volume in IL
$4,056 industry payments
Medicare Practice Summary
Medicare Utilization ↗37,852
Medicare services
Top 0% in IL for registered nurse
1,160
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,463 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 11,760 | $5 | $7 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,690 | $0 | $3 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
5,100 | $17 | $34 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,350 | $0 | $3 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
3,075 | $33 | $81 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,020 | $26 | $149 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
614 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 320 | $1 | $142 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
218 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
192 | $8 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
177 | $10 | $55 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
162 | $44 | $201 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
147 | $11 | $54 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
125 | $6 | $416 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
123 | $60 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
116 | $91 | $380 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
112 | $84 | $229 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
82 | $116 | $307 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
60 | $19 | $95 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
53 | $13 | $70 |
| Iron level test | 51 | $6 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
51 | $8 | $45 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
50 | $20 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $3 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $10 | $62 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
27 | $15 | $77 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
27 | $14 | $77 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
24 | $46 | $189 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
22 | $13 | $70 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $26 | $138 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
15 | $17 | $67 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.9% high complexity
46.1% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,056
Total received (2022-2024)
Avg $1,352/year across 3 years
Top 4% in IL for registered nurse
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,365 (82.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$692 (17.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,063
2023
$2,379
2022
$614
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Mirati Therapeutics, Inc.
$160
Janssen Biotech, Inc.
$126
Genentech USA, Inc.
$115
Daiichi Sankyo Inc.
$99
ABBVIE INC.
$76
Merck Sharp & Dohme LLC
$60
Novartis Pharmaceuticals Corporation
$52
Tempus AI, Inc
$47
JAZZ PHARMACEUTICALS INC.
$38
Hologic Sales and Service, LLC
$34
AstraZeneca Pharmaceuticals LP
$34
ARRAY BIOPHARMA INC
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
PFIZER INC.
$28
E.R. Squibb & Sons, L.L.C.
$26
Biocon Biologics Inc
$24
Pharmacosmos Therapeutics Inc.
$23
Alexion Pharmaceuticals, Inc.
$21
Aveo Pharmaceuticals, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$18
Top 3 companies account for 37.7% of 2024 payments
All-time payments by company (2022-2024) ›
ABBVIE INC.
$333
Janssen Biotech, Inc.
$276
Lilly USA, LLC
$271
Daiichi Sankyo Inc.
$210
AstraZeneca Pharmaceuticals LP
$202
E.R. Squibb & Sons, L.L.C.
$190
Regeneron Healthcare Solutions, Inc.
$189
Amgen Inc.
$185
Seagen Inc.
$177
Merck Sharp & Dohme LLC
$172
Mirati Therapeutics, Inc.
$160
Novartis Pharmaceuticals Corporation
$143
Genentech USA, Inc.
$132
JAZZ PHARMACEUTICALS INC.
$114
Gilead Sciences, Inc.
$112
Astellas Pharma US Inc
$93
Celgene Corporation
$80
GENZYME CORPORATION
$80
Takeda Pharmaceuticals U.S.A., Inc.
$77
PFIZER INC.
$76
Incyte Corporation
$71
SERVIER PHARMACEUTICALS LLC
$62
Pharmacyclics LLC, An AbbVie Company
$58
GlaxoSmithKline, LLC.
$47
Tempus AI, Inc
$47
Eisai Inc.
$46
G1 Therapeutics, Inc.
$45
Hologic Sales and Service, LLC
$34
TerSera Therapeutics LLC
$33
PharmaEssentia USA Corporation
$33
ARRAY BIOPHARMA INC
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Amneal Pharmaceuticals LLC
$26
BeiGene USA, Inc.
$24
Biocon Biologics Inc
$24
Agios Pharmaceuticals, Inc.
$24
EUSA Pharma (US) LLC
$23
Deciphera Pharmaceuticals Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$21
Alexion Pharmaceuticals, Inc.
$21
Aveo Pharmaceuticals, Inc.
$21
CTI BioPharma Corp.
$18
Top 3 companies account for 21.7% of all-time payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · ADCETRIS · ALUNBRIG · AVASTIN · BESREMI · BRAFTOVI · BRUKINSA · Blincyto · COSELA · CoolSeal Generator · DARZALEX · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FOTIVDA · Fulphila · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · NINLARO · Nubeqa · OPDIVO · OPDUALAG · PADCEV · PEMAZYRE · PLUVICTO · PYRUKYND · Padcev · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · SARCLISA · SCEMBLIX · Sylvant · TECVAYLI · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vonjo · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for registered nurse in IL.
Geographic Context
Registered nurses within 10 mi
2,051
Per 100K population
221.2
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krueger is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement in the top 4% of IL peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krueger experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Krueger performed 11,760 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krueger receive payments from pharmaceutical companies?
Yes. Dr. Krueger received a total of $4,056 from 43 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krueger's costs compare to other registered nurses in Hinsdale?
Dr. Krueger's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krueger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Registered Nurses in Hinsdale
Browse registered nurses in Hinsdale ranked by procedure volume and transparency data.
Highest volume
Top Registered Nurses in IL
Registered nurses ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Registered Nurses in IL
Which IL registered nurses receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology